Insulet (NASDAQ:PODD) Upgraded at Wolfe Research
Wolfe Research upgraded shares of Insulet (NASDAQ:PODD – Free Report) from a peer perform rating to an outperform rating in a research note published on Tuesday morning, MarketBeat reports. The firm currently has $350.00 target price on the medical instruments supplier’s stock. A number of other research analysts have also recently commented on PODD. Canaccord […]
Wolfe Research upgraded shares of Insulet (NASDAQ:PODD – Free Report) from a peer perform rating to an outperform rating in a research note published on Tuesday morning, MarketBeat reports. The firm currently has $350.00 target price on the medical instruments supplier’s stock. A number of other research analysts have also recently commented on PODD. Canaccord […]
